IL1B and atherosclerosis: Alternatively, this group may benefit from IL‐1B inflammatory blockade (Ridker et al., 2017), which has also been shown to be relevant to atherosclerosis in model systems of CHIP (Fuster et al., 2017; Jaiswal et al., 2017).